Premi Medical Agencies Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
as on 09-12-2024
- Paid Up Capital ₹ 0.90 M
as on 09-12-2024
- Company Age 31 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
as on 09-12-2024
- Satisfied Charges ₹ 8.50 M
as on 09-12-2024
- Revenue 21.31%
(FY 2023)
- Profit 10.34%
(FY 2023)
- Ebitda 54.85%
(FY 2023)
- Net Worth 8.64%
(FY 2023)
- Total Assets 26.61%
(FY 2023)
About Premi Medical Agencies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 0.90 M.
The company currently has active open charges totaling ₹2.00 Cr. The company has closed loans amounting to ₹8.50 M, as per Ministry of Corporate Affairs (MCA) records.
Raj Premi, Ankit Gupta, and Mukesh Premi serve as directors at the Company.
- CIN/LLPIN
U52311UP1993PTC015547
- Company No.
015547
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jul 1993
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Aligarh, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Premi Medical Agencies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukesh Premi  | Managing Director | 13-Jul-1993 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raj Premi | Director | 13-Jul-1993 | Current |
| Ankit Gupta | Director | 15-Nov-2010 | Current |
Financial Performance of Premi Medical Agencies.
Premi Medical Agencies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.31% increase. The company also saw a substantial improvement in profitability, with a 10.34% increase in profit. The company's net worth moved up by a moderate rise of 8.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Premi Medical Agencies?
Unlock access to Premi Medical Agencies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 18 Feb 2016 | ₹2.00 Cr | Open |
State Bank Of India Creation Date: 09 Sep 2009 | ₹6.50 M | Satisfied |
Canara Bank Creation Date: 13 Sep 2003 | ₹2.00 M | Satisfied |
How Many Employees Work at Premi Medical Agencies?
Unlock and access historical data on people associated with Premi Medical Agencies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Premi Medical Agencies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Premi Medical Agencies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
